Equities

Precipio Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
PRPO:NAQ

Precipio Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)23.39
  • Today's Change0.97 / 4.33%
  • Shares traded23.62k
  • 1 Year change+216.83%
  • Beta1.2294
Data delayed at least 15 minutes, as of Feb 13 2026 21:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Precipio, Inc. is a healthcare biotechnology company that is focused on cancer diagnostics. The Company’s technologies include HemeScreen and IV-Cell. The HemeScreen panels test for the presence of various mutations. In developing HemeScreen, it focused on improving the economics of providing blood cancer diagnostic tests and reducing laboratory technician time consumed in the testing process. Its technology enables testing to be completed in one rapid scanning process. IV-Cell is a cell culture media that addresses the problem of diagnostic mistakes through the process of selective culturing. IV-Cell is a universal media that enables simultaneous culturing of all four hematopoietic cell lineages. Its product category includes Molecular Kits and IV-Cell Cytogenetics Media. The Molecular Kits include Quantitative MPN Panel, ABL1 Resistance Panel, and others. The Company’s laboratory and research and development (R&D) facilities are located in New Haven, Connecticut and Omaha, Nebraska.

  • Revenue in USD (TTM)22.80m
  • Net income in USD-1.25m
  • Incorporated1997
  • Employees54.00
  • Location
    Precipio Inc4 Science ParkNEW HAVEN 06511United StatesUSA
  • Phone+1 (203) 787-7888
  • Fax+1 (302) 655-5049
  • Websitehttps://www.precipiodx.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Vaso Corp89.11m2.59m31.67m298.0012.261.129.560.35540.01470.01470.50650.16051.1334.0210.28299,030.203.277.375.3614.5660.9159.172.915.991.61--0.01--7.092.82-80.21--3.81--
EUDA Health Holdings Ltd5.16m-2.06m31.76m117.0054.37----6.150.01550.08760.1483-0.09982.49--17.1044,104.96-100.77------22.39---40.53--0.2084-46.54----8.22---108.62------
Ekso Bionics Holdings Inc14.75m-10.66m33.49m61.00--2.67--2.27-5.70-5.707.253.690.57991.362.27241,786.90-41.02-41.01-60.62-52.9053.4852.89-70.74-97.041.09--0.3055---1.945.1925.45---9.22--
RenovoRx Inc928.00k-11.11m34.21m10.00--4.23--36.86-0.4375-0.43750.03120.22040.0874----92,800.00-104.58-121.57-126.33-166.5067.78---1,196.66-90,830.235.68--0.00------13.86------
TELA Bio Inc77.06m-39.00m34.54m209.00--20.45--0.4483-0.8863-0.88631.750.03861.342.016.85368,684.20-68.06-51.29-96.57-60.7067.2366.26-50.61-88.022.62-7.250.9638--18.5635.0218.91---18.18--
Modular Medical Inc0.00-24.22m35.22m54.00--3.16-----0.5081-0.50810.000.14340.00----0.00-222.79-171.42-294.38-207.14------------0.00-------7.75--57.07--
Vivos Inc48.63k-3.01m35.42m10.00--16.25--728.32-0.0068-0.00680.00010.00480.0275--10.03---170.12-166.49-178.25-242.01-127.332.81-6,191.01-11,105.9819.81--0.00--43.5924.13-0.5424------
Precision Optics Corporation Inc21.58m-6.11m36.75m90.00--3.36--1.70-0.8505-0.85053.011.421.095.005.90239,722.70-30.82-13.63-45.79-19.5114.9929.56-28.30-11.580.785-28.850.1375---0.068513.98-95.85--7.81--
Icecure Medical Ltd2.98m-15.29m39.31m64.00--4.22--13.21-0.2586-0.25860.05010.13490.1960.823524.3946,484.38-100.74-61.14-155.92-77.1135.0650.17-513.95-343.951.90--0.00--1.9215.35-4.55---6.51--
Cytosorbents Corp34.35m-10.59m40.28m149.00--4.47--1.17-0.19-0.190.560.14360.73442.184.89230,553.30-22.63-34.58-28.22-41.8077.0270.00-30.81-62.081.71--0.6176--14.517.3729.16---15.13--
Precipio Inc22.80m-1.25m40.98m54.00--2.97169.341.80-0.835-0.83514.637.881.2018.2615.31422,222.20-6.58-38.01-8.60-46.9844.8233.80-5.50-71.341.10-24.190.074--21.9542.7426.70--32.31--
Neuroone Medical Technologies Corp12.10m-3.61m41.01m18.00--5.75--3.39-0.0784-0.07840.30120.14141.501.6316.79672,094.40-44.63-113.64-61.95-152.0867.3060.94-29.80-223.443.47--0.1519--250.3544.4170.73---7.76--
electroCore, Inc.29.84m-14.16m43.42m73.00------1.46-1.70-1.703.59-0.14051.412.6329.39408,698.60-66.70-65.38-126.40-87.8786.0480.72-47.46-159.341.33--1.20--57.0960.1536.89------
Heartbeam Inc0.00-20.62m45.81m16.00--112.50-----0.6638-0.66380.000.01180.00----0.00-432.60-142.55-792.01-190.45------------0.00-------32.85------
Spectral AI Inc23.17m-16.37m47.57m78.00------2.05-0.7206-0.72060.9706-0.3011.7228.4112.12297,025.70-121.66------45.01---70.64--0.8252-11.99----63.83--26.56------
Nutriband Inc2.28m-34.59m50.04m13.00--6.62--21.96-3.07-3.070.20030.6210.21749.9617.72---121.91-66.47-134.92-78.0433.5037.16-560.85-340.947.35--0.022--2.6041.99-91.10------
Data as of Feb 13 2026. Currency figures normalised to Precipio Inc's reporting currency: US Dollar USD

Institutional shareholders

18.87%Per cent of shares held by top holders
HolderShares% Held
AMH Equity Ltd.as of 31 Dec 2025158.64k9.05%
Topline Capital Management LLCas of 30 Sep 202565.10k3.72%
BlackRock Fund Advisorsas of 31 Dec 202528.91k1.65%
Geode Capital Management LLCas of 31 Dec 202516.39k0.94%
The Vanguard Group, Inc.as of 31 Dec 202516.21k0.93%
Renaissance Technologies LLCas of 31 Dec 202514.50k0.83%
G1 Execution Services LLCas of 30 Sep 202510.80k0.62%
Evernest Financial Advisors LLCas of 31 Dec 202510.60k0.61%
Vanguard Fiduciary Trust Co.as of 31 Dec 20259.35k0.53%
Wells Fargo Advisors Financial Network LLCas of 31 Dec 202550.000.00%
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.